---
title: "QLGN.US (QLGN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/QLGN.US/news.md"
symbol: "QLGN.US"
name: "QLGN.US"
parent: "https://longbridge.com/en/quote/QLGN.US.md"
datetime: "2026-03-03T14:08:01.444Z"
locales:
  - [en](https://longbridge.com/en/quote/QLGN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/QLGN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/QLGN.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/QLGN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/QLGN.US/news.md)


# QLGN.US (QLGN.US) — Related News

### [Qualigen Therapeutics Regains Nasdaq Compliance After Shareholder Approval Issue](https://longbridge.com/en/news/266982306.md)
*2025-11-21T21:31:03.000Z*
> Qualigen Therapeutics Inc. has regained compliance with Nasdaq Listing Rule 5635(b) after obtaining shareholder approval

### [Qualigen Therapeutics Appoints Koti Meka as Executive Director and Jie Sheng as Chairman](https://longbridge.com/en/news/266810538.md)
*2025-11-20T22:11:06.000Z*
> Qualigen Therapeutics Inc. has announced management changes effective November 17, 2025. Koti Meka is appointed as Execu

### [Qualigen Therapeutics Inc. held shareholder meeting](https://longbridge.com/en/news/266087342.md)
*2025-11-16T21:14:22.000Z*
> Qualigen Therapeutics Inc. held a Special Meeting of Stockholders on November 16, 2025, approving all proposals includin

### [Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy | QLGN Stock News](https://longbridge.com/en/news/266087265.md)
*2025-11-16T21:10:00.000Z*
> Qualigen Therapeutics shareholders approved all proposals, leading to a rebranding as AIxCrypto Holdings, Inc. (Nasdaq: 

### [Qualigen Therapeutics | 10-Q: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/265991740.md)
*2025-11-14T22:18:40.000Z*
### [QLGN will change its name to AIxCrypto after the shareholders' meeting on November 12th, and plans to increase the size of its crypto treasury to $50 million.](https://longbridge.com/en/news/263076160.md)
*2025-10-28T11:49:00.000Z*
> Nasdaq-listed Qualigen Therapeutics (QLGN) announced that it will change its name to AIxCrypto after its November 12th s

### [Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025](https://longbridge.com/en/news/263000273.md)
*2025-10-28T04:03:53.000Z*
> Dubai, UAE / Beijing, China, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Qualigen Therapeutics Inc. ( NASDAQ: QLGN ) ( "Qualigen